All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma

por Fante, Matthias A., Felsenstein, Mona, Mayer, Stephanie, Gerken, Michael, Klinkhammer-Schalke, Monika, Herr, Wolfgang, Vogelhuber, Martin, Reichle, Albrecht, Heudobler, Daniel
Publicado 2022